Dina Manetti

Via U. Schiff 6
Sesto Fiorentino, 50019, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy.

Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy.

Journal: Biomolecules

Published: June 23, 2026

Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice.

Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice.

Journal: ACS chemical neuroscience

Published: May 01, 2026

Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes.

Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes.

Journal: ChemMedChem

Published: February 24, 2026

New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli.

New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli.

Journal: Bioorganic & medicinal chemistry letters

Published: February 05, 2026

Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor.

Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor.

Journal: Biochemical pharmacology

Published: March 25, 2025

Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors.

Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 02, 2024

The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naïve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission.

The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naïve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: September 18, 2024

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Journal: Molecules (Basel, Switzerland)

Published: May 29, 2024

Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic Cortex.

Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic Cortex.

Journal: Neurochemistry international

Published: April 04, 2024

Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation.

Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 29, 2024

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Journal: Molecules (Basel, Switzerland)

Published: November 24, 2023

The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation.

The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation.

Journal: European journal of pharmacology

Published: October 30, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026